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S U M M A R Y
Phagocytic cells o f  patients with chronic granulom atous  disease (C G D ) are severely 
impaired in the killing process, on the basis o f  defective oxygen metabolism. In this study 
we investigated the antigen-presenting function of  monocytes (i.e. adherent cells) o f  C G D  
patients. Adherent cells of  C G D  patients were investigated for their capacity to present 
ovalbumin (OA) in such a way that T helper cclls are activated and OA-specific IgM- 
plaquc forming cells (PFC) are generated. The results showed that the dose of  OA 
required for optimal PFC responses was 20-25 times higher than the dose o f  antigen 
which is necessary for induction of  PFCs from peripheral blood mononuclear  cells of  
normal donors.  We could show that the C G D  monocytes were responsible for the 
observed shift which indicates peculiar antigen-presenting capacities. The finding could be 
mimicked in normal donors  by treating adherent cells with phenylbutazone, a drug known 
to interfere with oxygen-dependent degradation o f  micro-organisms. Moreover,  our 
results suggested that C G D  monocytes and phenylbutazone-treated monocytes o f  normal 
donors  absorb  OA but do not re-express the processed antigen on the membrane. We 
conclude that our  system used to study antigen presentation allowed the discovery of  
altered antigen presentation of  C G D  monocytes most probably on the basis o f  defective 
antigen processing. However, antigen presentation is not entirely absent, since relatively 
high doses o f  OA induced normal PFC  responses in C G D  mononuclear  cells.
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I N T R O D U C T I O N
An essential step in the activation o f  T helper cells by complex antigens is the presentation of  the 
antigen by accessory cells in conjunction with Class II molecules o f  the M H C  complex (Rosental & 
Shevach, 1973; Benaccrraf, 1981). T  helper cells do not recognize antigens in their native form but 
they only respond to ‘processed’ antigens presented on the surface o f  the accessory cells ( Benacerraf, 
1981; Ziegler & Unanue,  1981).
Processing of  antigen by accessory cclls involves a sequence o f  events comprising recognition 
and ingestion o f  the antigen, and degradation and re-expression o f  the antigen on the membrane
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(Ziegler & Unanue,  1981; Ziegler & Unanue,  1982). However, in more recent years the necessity of  
processing o f  antigen lor effective presentation to T helper cells has been disputed.
In previous studies we have reported on the regulatory role o f  T cells and monocytes (i.e. 
adherent cells) in the in-vitro activation o f  human peripheral blood B lymphocytes with antigens 
like ovalbumin (OA) and sheep red blood cells (Ballieux et a/., 1979; Heijnen et a/., 1981). In this 
system antigen-presenting monocytes and antigen-specific T helper and T suppressor lymphocytes 
interact in the activation o f  antigen-specilic resting B cclls into the stage o f  a small IgM-secreting 
plaque forming cell (PFC) (Ballieux & Heijnen, 1983; Van Tol et a/., 1984; 't Har t  et al., 1985). In the 
present study it was investigated whether peripheral blood monocytes from patients with chronic 
granulomatous  disease (CG D) can present OA in such a way that T helper cells are activated and 
OA-specific IgM-PFCs are generated. In this way monocytes defective in oxygen metabolism 
(Gallin & Fauci, 1983) are used as a model to study antigen presentation.
M A T E R I A L S  A N D  M E T H O D S
Mononuclear cell isolation. Peripheral blood mononuclear  cells were isolated by density gradient 
centrifugation as described by Heijnen et al. (1979).
Monocyte depletion and isolation. Monocytes were isolated from the mononuclear  ccll 
suspension (1 x 10(’ cells/ml) by allowing them to adhere to plastic Falcon flasks at 37 C in RPM I- 
1640 medium (Gibco) supplemented with 20°,, fetal calf serum (FCS). After 60 min o f  incubation at 
37 C the supernatant  containing the lymphocytes was decanted and the adherent  cells were 
harvested by gently scraping with a rubber policeman and then collected in Earle's balanced salt 
solution without calcium and magnesium (Gibco) supplemented with 0 002 m EDTA.
Cell cultures. This method has been described extensively (Heijnen et al.. 1979). In brief, 5 x  106 
peripheral blood lymphocytes (PBL) were cultured in the presence of  the antigen ovalbumin (OA; 
Grade  VI. Sigma, St Louis) and 10"o adherent cells. Cultures were performed in roundbot tom  tubes 
(Falcon) in 10 ml medium which consisted o f  RPMI-1640. supplemented with 2 m.vi L-gutamine, 
antibiotics and 10"o human AB serum. Before use the serum was heat-inactivated and extensively 
absorbed with sheep red blood cells (SE) to prevent pseudoplaque formation (Ballieux et al., 1979).
Pulsing o f  adherent cells with OA. Monolayers o f  adherent cells were incubated with 1000 //g 
OA ml RPMI-1640 supplemented with 10"/.. heat-inactivated SE-absorbed AB serum for 2 h. After 
the incubation period the cells were harvested and washed three times with RPMI-1640 
supplemented with 5 %  pre-treated AB serum.
Enzyme treatment o f  the adherent cells. Adherent cclls ( lO x  10(> cells/ml RPMI-1640) were 
incubated with pronase (8 mg ml. Sigma, St Louis) and DNAse (10 //g/ml) for 30 min at 37 C. After 
the incubation 1 ml FCS was added to the cells which were spun down (4 C) and washed twice with 
RPMI-1640 supplemented with 10% FCS.
Phenylbutazone treatment. Monolayers o f  adherent cells were incubated with phenylbutazone 
(100 fig/ml) for 30 min at 37 C. After this procedure the cells were washed twice.
Plaque forming ccll assay. PFC  were determined as described in detail earlier (Ballieux et al.. 
1979; Heijnen et al., 1979). In brief. OA-coated SE (Heijnen et al., 1979; Goding, 1969) were 
centrifuged for 5 min at 1000 g on the bottom o f  Falcon microtitre plates, coated by incubation with 
poly-L-lysine (Sigma. St Louis, M r^  100,000) in a concentration of  100 //g/ml distilled water. OA- 
stimulated cells in various dilutions were incubated for 60-90 min in the presence of  SE-absorbed 
guinea pig complement (C). Controls  comprised the addition of  cultured cells to the monolayers 
without C and vice versa. Only IgM-PFCs are detected in this system and antigen-spccificity has 
been investigated extensively as described earlier (Ballieux et a i , 1979; Heijnen et al., 1979).
R E S U L T S
PFC-response of PBL from normal donors and o f  CGD patients. PBL from normal donors  and 
from four C G D  patients were cultured with various doses o f  the antigen ovalbumin (OA) for 6 days
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at 37 C. After the incubation period, the cells were harvested and tested for their capacity to secrete 
IgM a n t i -0 A  antibodies in vitro by measuring the num ber  o f  anti-OA PFC (Heijnen et al., 1979).
It was shown that in PBL from normal donors  formation of  PFC can be generated when the 
dose o f  antigen in the eulture is in between 1 and 3 pg OA/ml (Fig. 1). When normal PBL are 
stimulated with 100 pg OA or more, the PFC-response decreases to baseline levels. We have shown 
previously that the decline in the PFC-response of  lymphocytes cultured in the presence of  the high 
concentration of  antigen is due to the activation of  T suppressor effector cells (UytdeHaag,  Heijnen 
& Ballieux, 1978). However, when PBL of C G D  patients are cultured with various doses of  antigen, 
a shift o f  the PFC-response towards the right side of  the curve was observed in all patients, with an 
optimal PFC-response at 100 //g OA/ml (Fig. 1).
PFC-response o f  lymphocytes o f  normal donors and o f  CGD patients after stimulation with 
antigen-pulsed adherent cells. To  study the process o f  antigen-presentation by accessory cells of  
C G D  patients more precisely, adherent  cells of  both C G D  patients and normal donors  were pulsed 
with ovalbumin (1000 pg OA/ml) for 2 h at 37 C. After the incubation period, the non-adhered 
antigen was washed away and the pulsed cells were cultured for 6 days with PBL that were depleted 
of  adherent cells under s tandard conditions. The results depicted in the upper part  o f  Fig. 2 show
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Fig. 1. PFC  response o f  C G D  patients (□, // =  4) and normal control  donors  (□, // =  4), generated in the presence 
o f  various doses o f  the antigen OA. Lymphocytes (5 x 10'’) (T/B ratio: about  7/1) were cultured with OA and 
10"() adherent  cclls. The T/B ratio in C G D  patients and normal donors  did not dilTer significantly. OA-specific 
IgM-PFCs were measured after 6 days o f  culture.
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Fig. 2. PFC  response o f  PBL (5 x I06) from C G D  patients (□,/? =  5) and o f  normal control  donors  (□, n = 5) in 
the presence o f  10% OA-pulsed adherent cells. * Assay system: PBL depleted o f  adherent  cells and reconstituted 
with the indicated adherent  cell suspensions. Background values (PBL cultured with 10% non-pulsed adherent  
cells) are less than 200 PFC.
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that C G D  lymphocytes cultured with antigen-pulsed adherent cclls mount  a PFC-response which 
indicates that C G D  adherent cclls are able to present antigen. However, the PFC  response obtained 
is much lower than that  o f  cultures o f  antigen-pulsed adherent cclls and lymphocytes o f  control 
donors.
PFC-response o f  normal donors and o f  CGD patients after stimulation with antigen-pulsed, 
pronase-treated adherent cells. Next, it was investigated whether the PFC-response observed in 
cultures o f  antigen-pulsed monocytes and lymphocytes o f  C G D  patients is actually the result o f  
antigen-processing and re-expression o f  the antigen on the membrane of  the adherent  cclls.
To that end. antigen-pulsed adherent cells were ‘stripped' by pronase-treatment to remove cell- 
bound antigen that had not yet been ingested. After several washing procedures the adherent  cclls 
were added to the lymphocyte suspension that was depleted of  adherent cells and cultured for 6 
days.
These experiments show that when the adherent cells o f  C G D  patients are clcarcd from cell- 
bound antigen, the antigen-pulsed adherent ccll population is incapable o f  inducing a PFC- 
response (lower part  of  Fig. 2). This finding suggests that surface-bound OA is responsible for the 
low PFC  response obtained when antigen-pulsed adherent cells, not treated with pronase, were used 
for induction of  PFCs. Unlike C G D  adherent cells, antigen-pulsed pronase-treated adherent  cells 
from normal donors  can activate the lymphocytes, leading to the differentiation o f  resting B cells 
into IgM-secreting PFCs (Fig. 2).
PFC-response o f  PBL from  normal donors in the presence o f  adherent cells treated with 
phenylbutazone. In the next scries o f  experiments, we tried to mimic the delect o f  monocytes o f  C G D  
patients, by pre-incubating normal adherent  cells with phenylbutazone (100 //g/ml). This agent is 
known to inhibit intracellular killing o f  phagocytes, probably by interference with the hexose 
m onophosphate  shunt (Solbey, 1975). When normal adherent cclls arc pre-treated with phenylbu­
tazone for 30 min and cultured with PBL and various doses of  OA for 6 days, a shift towards the 
right of the PFC-response curve is observed, resembling the PFC-antigen dose relationship o f  C G D  
patients (Figs 1 and 3).
PFC-response o f  PBL o f  normal donors in the presence o f  phenylbutazone-treated, antigen-pulsed 
and pronase-treated adherent cells. Normal  adherent cells, pre-treated either with medium or with 
phenylbutazone, were pulsed with antigen for 2 h. After the pulse-period, one part  o f  the cells was 
subsequently treated with pronase to remove cell-bound antigen. After several washing procedures 
the adherent cell preparations were added separately to lymphocyte suspensions which were 
carefully depleted of  adherent cells, and cultured for 6 days at 37 C. Figure 4 demonstrates  that
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Fig. 3. PFC response o f  PBL from normal donors  with either phenylbutazone treated adherent cells (□,  n =  4) or 
untreated cells (□,  // =  4) in the prcscnce o f  various doses of  OA.
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Fig. 4. PFC  response o f P B L  from normal donors  in the presence o f  adherent  cells treated as indicated
indeed phenylbutazone treatment mimics the results obtained with the adherent cells o f  C G D  
patients (Fig. 2), i.e. PFC  are generated in cultures with phenylbutazone-treated adherent cells but 
just as in C G D  patients the results are lower than with untreated adherent cells. When 
phenylbutazone-treated,  antigen-pulsed adherent cells are cleared of  cell-bound antigen, the 
adherent  cells are no longer capable of  presenting the antigen in such a way that it leads to PFC 
formation.
D I S C U S S I O N
The question whether the antigen has to be processed by an accessory ccll and re-expressed on the 
mem brane  before it can activate T helper cells is a subject of  intense investigation (Unanue  et al., 
1984). In contrast to T helper cells. T  suppressor (Ts) cells recognizc the antigen in its soluble form, 
since T s cells can be stimulated efficiently in the absence o f  monocytes with low doses o f  antigen 
(0-003 f.ig OA/ml; U ytdeH aag  et al., 1982). However, when the num ber  o f  adherent cells in the 
culture is increased, more antigen is required (30-100 /.ig OA/ml at 10% adherent cells) to activate T 
suppressor cells (U ytdeHaag  el al., 1982). The bell-shaped PFC-response curve is therefore a 
reflection o f  the net result o f  the balance between T  helper and T suppressor cell activities induced by 
the various doses o f  antigen (Ballieux et al., 1979).
When mononuclear  cclls from C G D  patients are cultured with various doses o f  OA, the PFC- 
response curve has an optimum at 100 //g OA/ml, indicating that unlike normal donors  relatively 
high doses o f  antigen are required to let Th cell activity prevail over T s activity. In separate 
experiments it was shown that C G D  mononuclear  cells produced neither OA-specihc T helper cell 
factors nor OA-specific T suppressor ccll factors (Ballieux et al., 1979; Heijnen et al., 1981) at a 
concentration of  3 ¡ig OA/ml (data not shown). The latter finding indicates that with this dose o f  OA 
no free antigen is available to activate T s cells which suggests that OA is internalized in the C G D  
monocytes without induction of  T  helper function. When subsequently adherent cells are pulsed 
with antigen, extensively washed and treated with pronase to remove non-ingested cell-bound 
antigen, the PFC-response is abolished (Fig. 2). We therefore conclude that the adherent cells of  
C G D  patients apparently do not process the antigen in a way it is rc-exprcssed on the membrane for 
the activation of  T  helper cells. From the data  presented it appeared that adherent cells o f  C G D  
patients that have been pulsed with OA but not stripped for non-ingested OA can present antigen to 
T helper cells, a l though the PFC- responses are much lower than those of  normal donors  (Fig. 2). 
These results imply that there are T cells present in the peripheral circulation that can recognize 
antigen that has not been processed by monocytes. We do not yet know whether the antigen is
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partially processed at the level o f  the membrane o f  the adherent cells or whether enzymes present in 
the AB serum pool can partially degrade the antigen. It might also be possible that a specialized 
subset o f  antigen-presenting cells, e.g. dendritic cclls which are known to be capable o f  stimulating T 
helper cclls without ingesting and processing the antigen (Van Voorhis et al., 1982). is responsible 
for the presentation of  the antigen to the T helper cclls.
The present result, i.e. a shift o f  the OA-dosc response towards high concentrat ions in 
mononuclear  cells o f  C G D  patients, is reminiscent o f  earlier observations using cord blood 
mononuclear  cells. In this respect van Toi et al. ( 1984) showed that neonatal and adult adherent cells 
differ in antigen-handling which is rcflcctcd in a shift o f  the OA dose needed to induce an optimal 
PFC response in cord blood cells to low (i.e. 0 03 //g) concentrations. In addit ion it was shown that 
neonatal adherent cells sccrctc more PGE2 than adherent cclls from adult  controls. The difference 
between the adult and cord blood dose response curves could be abolished by treatment with 
indomethacine, an inhibitor o f  cyclooxyeenase. These results suggest a relation to exist betweenm y  Km*
antigen-handling and PGE2 secretion and /o r  sensitivity. We did not measure PGE2 secretion by 
C G D  adherent cells but, unlike our  results, one would expect that if PGE2 secretion by C G D  
adherent cclls is increased, a shift o f  the antigen-dose/'PFC relationship towards low concentrat ions 
would be obtained. It should be mentioned that the C G D  patients had no overt infections when 
investigated. Furthermore  several patients with infections were investigated for PFC responses in 
the last years in our  laboratory. However a shift in the antigcn-dose response relationship towards 
high antigen concentrations was never observed.
In order to demonstra te  more directly that the abbcrant  PFC-responses are due to a defccl in the 
antigen-presenting cells, we tried to mimic the defect o f  monocytes of  C G D  patients by treating 
adherent cells from normal donors  with phenylbutazone. The latter drug interferes with oxygen- 
dependent degradation by inhibiting H :0 : production through an effect on the hexose m onophos­
phate shunt pathway (Soleby, 1975). The PFC dose response using phenylbutazone-treated 
adherent cells of  normal donors  completely mimics those of  C G D  patients. Furthermore,  results 
using antigen-pulsed adherent cclls pretreated with phenylbutazone and stripped with pronase 
show unequivocally that the adherent cclls are no longer capable o f  presenting the antigen in a way 
that it can activate T helper cells. These results indicate also that oxygen-dependent biochemical 
pathways play an important  role in antigen-processing and presentation of  OA. The importance o f  
lysosomal degradation is suggested by data  from Allen & U nanue  (1984), who showed that agents 
like chloroquine inhibit the subsequent activation of  T  helper cells.
Taking these data together we can conclude that under the particular circumstances o f  our  in- 
vitro system adherent cells o f  C G D  patients can internalize the antigen, but are defective in the 
presentation of  the antigen in a processed form to human peripheral blood T helper cells. 
Consequently a dcfect in oxygen metabolism may interfere at some stage with antigen-processing of  
OA, possibly since oxidants needed to denature  sulfhydryl-containing proteins like OA before 
processing are lacking (Weiss, Lampert & Test. 1983).
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